30.04
price down icon5.24%   -1.66
after-market アフターアワーズ: 29.99 -0.05 -0.17%
loading
前日終値:
$31.70
開ける:
$31.58
24時間の取引高:
1.34M
Relative Volume:
1.22
時価総額:
$1.65B
収益:
$199.89M
当期純損益:
$52.48M
株価収益率:
35.34
EPS:
0.85
ネットキャッシュフロー:
$61.15M
1週間 パフォーマンス:
-6.94%
1か月 パフォーマンス:
+27.83%
6か月 パフォーマンス:
+207.79%
1年 パフォーマンス:
+143.04%
1日の値動き範囲:
Value
$28.10
$31.58
1週間の範囲:
Value
$28.10
$33.88
52週間の値動き範囲:
Value
$5.35
$38.69

Stoke Therapeutics Inc Stock (STOK) Company Profile

Name
名前
Stoke Therapeutics Inc
Name
セクター
Healthcare (1135)
Name
電話
781-430-8200
Name
住所
45 WIGGINS AVENUE, BEDFORD, MA
Name
職員
128
Name
Twitter
@stoketx
Name
次回の収益日
2025-03-18
Name
最新のSEC提出書
Name
STOK's Discussions on Twitter

STOK を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
STOK
Stoke Therapeutics Inc
30.04 1.74B 199.89M 52.48M 61.15M 0.85
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
425.57 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
651.80 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.04 58.93B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
818.50 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
189.60 41.29B 447.02M -1.18B -868.57M -6.1812

Stoke Therapeutics Inc Stock (STOK) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-18 開始されました Jefferies Buy
2024-12-20 開始されました Chardan Capital Markets Buy
2024-10-14 再開されました Leerink Partners Outperform
2024-03-26 アップグレード TD Cowen Market Perform → Outperform
2023-11-20 再開されました JP Morgan Neutral
2023-07-25 ダウングレード TD Cowen Outperform → Market Perform
2023-05-01 アップグレード BofA Securities Underperform → Neutral
2023-04-26 再開されました Canaccord Genuity Buy
2023-01-06 ダウングレード BofA Securities Buy → Underperform
2022-10-24 アップグレード SVB Leerink Mkt Perform → Outperform
2022-01-31 開始されました Jefferies Buy
2021-12-03 開始されました BofA Securities Buy
2021-11-22 アップグレード JP Morgan Neutral → Overweight
2021-05-18 開始されました UBS Neutral
2021-05-10 アップグレード Wedbush Neutral → Outperform
2021-04-26 再開されました Credit Suisse Outperform
2021-02-10 ダウングレード Wedbush Outperform → Neutral
2020-12-15 再開されました H.C. Wainwright Buy
2020-12-11 繰り返されました Needham Buy
2020-10-23 開始されました Cantor Fitzgerald Overweight
2020-09-29 再開されました JP Morgan Neutral
2020-09-29 開始されました Needham Buy
2019-12-18 開始されました Wedbush Outperform
2019-11-12 開始されました BTIG Research Buy
2019-10-25 開始されました H.C. Wainwright Buy
2019-07-15 開始されました Canaccord Genuity Buy
2019-07-15 開始されました Cowen Outperform
2019-07-15 開始されました Credit Suisse Outperform
2019-07-15 開始されました JP Morgan Overweight
すべてを表示

Stoke Therapeutics Inc (STOK) 最新ニュース

pulisher
02:00 AM

Live market analysis of Stoke Therapeutics Inc.Insider Selling & Weekly Return Optimization Plans - newser.com

02:00 AM
pulisher
01:29 AM

Does Stoke Therapeutics Inc. show high probability of rebound2025 Volume Leaders & Technical Analysis for Trade Confirmation - newser.com

01:29 AM
pulisher
01:52 AM

Stoke Therapeutics, Inc. (NASDAQ:STOK) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

01:52 AM
pulisher
Nov 01, 2025

Stoke Therapeutics Shares Plunge Following Clinical Trial Data Release - AD HOC NEWS

Nov 01, 2025
pulisher
Nov 01, 2025

Stoke Therapeutics (NASDAQ:STOK) Stock Price Down 6.3%Should You Sell? - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Will Stoke Therapeutics Inc. stock maintain momentum in 2025Weekly Profit Recap & Precise Swing Trade Entry Alerts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Is Stoke Therapeutics Inc. stock a good choice for value investorsTrade Entry Report & Short-Term Trading Opportunity Alerts - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

What insider trading reveals about Stoke Therapeutics Inc. stockTrade Risk Assessment & Daily Technical Forecast Reports - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Stoke Therapeutics Inc expected to post a loss of 57 cents a shareEarnings Preview - TradingView

Oct 31, 2025
pulisher
Oct 31, 2025

Exit strategy if you’re trapped in Stoke Therapeutics Inc.July 2025 Macro Moves & Weekly High Return Opportunities - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Stoke Therapeutics, Inc. (STOK) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Oct 30, 2025
pulisher
Oct 30, 2025

Total debt per share of Stoke Therapeutics, Inc. – BER:0GT - TradingView

Oct 30, 2025
pulisher
Oct 30, 2025

Stoke Therapeutics to Host Webcast and Conference Call to Discuss Third Quarter 2025 Business and Financial Updates - Yahoo Finance

Oct 30, 2025
pulisher
Oct 29, 2025

Stoke Therapeutics (STOK) Price Target Increased by 16.51% to 28.79 - Nasdaq

Oct 29, 2025
pulisher
Oct 28, 2025

Stoke Therapeutics (STOK) Projected to Post Earnings on Tuesday - MarketBeat

Oct 28, 2025
pulisher
Oct 28, 2025

Will Stoke Therapeutics Inc. stock maintain dividend yieldExit Point & AI Forecast for Swing Trade Picks - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Why Stoke Therapeutics Inc. stock is popular among millennialsTrade Performance Summary & Stock Market Timing Techniques - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 27, 2025

Take Profit: Is Stoke Therapeutics Inc. stock a good choice for value investorsTrade Risk Summary & Target Return Focused Stock Picks - fcp.pa.gov.br

Oct 27, 2025
pulisher
Oct 27, 2025

Dravet Syndrome Pipeline 2025: Key Developments, Emerging - openPR.com

Oct 27, 2025
pulisher
Oct 27, 2025

How Stoke Therapeutics Inc. stock trades before earningsDividend Hike & Step-by-Step Swing Trade Plans - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 26, 2025

Weiss Ratings Reaffirms Sell (D+) Rating for Stoke Therapeutics (NASDAQ:STOK) - MarketBeat

Oct 26, 2025

Stoke Therapeutics Inc (STOK) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$37.54
price up icon 1.62%
$93.48
price up icon 0.96%
$28.61
price down icon 0.21%
$103.91
price down icon 0.73%
biotechnology ONC
$310.48
price up icon 0.73%
$189.60
price down icon 2.38%
大文字化:     |  ボリューム (24 時間):